Are Chinese Patients with Type 2 Diabetes and a Body Mass Index of 27.5–32.5 kg/m2 Suitable for Metabolic Surgery? A One-Year Post-Surgery Study

Are Chinese Patients with Type 2 Diabetes and a Body Mass Index of 27.5–32.5 kg/m2 Suitable for Metabolic Surgery? A One-Year Post-Surgery Study

Introduction The aim of this study was to clarify the efficacy and safety of metabolic surgery in Chinese patients with type 2 diabetes mellitus (T2DM) and a body mass index (BMI) of 27.5–32.5 kg/m 2 . Methods A total of 99 patients with T2DM were enrolled in this retrospective cohort study. Of thes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes therapy 2021-05, Vol.12 (5), p.1429-1444
Hauptverfasser: Zhang, Ning-Jing, Fu, Yu-Zhe, Shan, Xiao-Dong, Zhang, Ning, Sun, Xi-Tai, Chu, Xue-Hui, Bi, Yan, Zhu, Da-Long, Feng, Wen-Huan
Format: Artikel
Sprache:eng
Schlagworte:
Antidiabetics
Body mass index
Cardiology
Diabetes
Endocrinology
Gastrointestinal surgery
Hemoglobin
Internal Medicine
Medicine
Medicine & Public Health
Metabolism
Original Research
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction The aim of this study was to clarify the efficacy and safety of metabolic surgery in Chinese patients with type 2 diabetes mellitus (T2DM) and a body mass index (BMI) of 27.5–32.5 kg/m 2 . Methods A total of 99 patients with T2DM were enrolled in this retrospective cohort study. Of these patients, 53 had a BMI of 27.5–32.5 kg/m 2 and had undergone metabolic surgery ( n = 21) or were on conventional antidiabetic therapy ( n = 32)]; 46 had a BMI ≥ 32.5 kg/m 2 and all had undergone metabolic surgery. Primary endpoints included the triple endpoint [hemoglobin A1c 
ISSN:1869-6953
1869-6961
DOI:10.1007/s13300-021-01027-9